{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:31:16Z","timestamp":1740130276820,"version":"3.37.3"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Institute for Health Research Clinical Lectureship"},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21173","21754","21755"],"award-info":[{"award-number":["21173","21754","21755"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.1093\/rheumatology\/kead613","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T18:23:34Z","timestamp":1700245414000},"page":"e118-e119","source":"Crossref","is-referenced-by-count":1,"title":["IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-7353","authenticated-orcid":false,"given":"Sizheng Steven","family":"Zhao","sequence":"first","affiliation":[{"name":"Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre , Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0002-1907","authenticated-orcid":false,"given":"Matthew C","family":"Baker","sequence":"additional","affiliation":[{"name":"Division of Immunology and Rheumatology, Department of Medicine, Stanford University , Stanford, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1230-2781","authenticated-orcid":false,"given":"James B","family":"Galloway","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, King's College London , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"2024040216351936800_kead613-B1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2249.1997.d01-905.x","article-title":"Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters","volume":"107","author":"Takizawa","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2024040216351936800_kead613-B2","first-page":"100004","article-title":"Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents","volume":"1","author":"Sharp","year":"2019","journal-title":"Respir Med X"},{"key":"2024040216351936800_kead613-B3","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kead373","article-title":"A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis","author":"Baker","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2024040216351936800_kead613-B4","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3899\/jrheum.130278","article-title":"Sarcoidosis induced by tocilizumab: a paradoxical event?","volume":"40","author":"Nutz","year":"2013","journal-title":"J Rheumatol"},{"key":"2024040216351936800_kead613-B5","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2022-222578","article-title":"Genetically proxied IL-6 receptor inhibition and risk of polymyalgia rheumatica","author":"Zhao","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2024040216351936800_kead613-B6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jama.2022.15459","article-title":"Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial","volume":"328","author":"Devauchelle-Pensec","year":"2022","journal-title":"JAMA"},{"key":"2024040216351936800_kead613-B7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/CIRCULATIONAHA.120.052604","article-title":"Genetically downregulated interleukin-6 signaling is associated with a favorable cardiometabolic profile","volume":"143","author":"Georgakis","year":"2021","journal-title":"Circulation"},{"key":"2024040216351936800_kead613-B8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/ard-2022-223513","article-title":"Genetically proxied TYK2 inhibition is associated with reduced sarcoidosis susceptibility","volume":"82","author":"Zhao","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead613\/53962147\/kead613.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/4\/e118\/57140471\/kead613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/4\/e118\/57140471\/kead613.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T18:24:27Z","timestamp":1712082267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/4\/e118\/7425446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":8,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,17]]},"published-print":{"date-parts":[[2024,4,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead613","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"type":"print","value":"1462-0324"},{"type":"electronic","value":"1462-0332"}],"subject":[],"published-other":{"date-parts":[[2024,4,1]]},"published":{"date-parts":[[2023,11,17]]}}}